Atorvastatin Calcium
Product Images NDC 60760-979

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorv (Atorvastatin 60760 979 30)

Atorv (Atorvastatin 60760 979 30)
Label for Atorvastatin Calcium tablets USP 40 mg, package of 30 tablets, manufactured by MSN Laboratories Private Limited, Telangana, India. Distributed by St Mary's Medical Park Pharmacy, Oro Valley, AZ 85737. Includes NDC 60760-979-30 and storage instructions to keep at controlled room temperature 15°-30°C (59°-86°F).*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

Figure-01 (Atorvastatin Figure 01)
A line graph showing cumulative incidence percentages over a 3.5-year period comparing Atorvastatin with Placebo. The solid line represents Atorvastatin, and the dashed line represents Placebo, illustrating lower cumulative incidence for Atorvastatin compared to Placebo throughout the timeframe.*
FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
A cumulative hazard plot showing time to first primary endpoint over four years of follow-up comparing Atorvastatin (solid line) to placebo (dashed line). The y-axis represents cumulative hazard percentage, and the x-axis represents years. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
A line graph showing the percentage of subjects experiencing an event over time (up to 5 years) comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis measures time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event.*
FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure of atorvastatin calcium, including the calcium ion and associated waters of hydration, showing the molecular arrangement of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.